Everlywell and Jona teamed up to expand consumer access to a gut microbiome test through Everlywell’s digital health platform. The partnership aims to increase reach for Jona’s microbiome offering by integrating ordering and distribution into Everlywell’s consumer pipeline. For biotech and diagnostics stakeholders, the deal reflects continued growth in direct-to-consumer microbiome testing and the emphasis on channel partnerships to drive adoption. It also highlights how established e-commerce and clinical-adjacent platforms are being used to scale IVD-adjacent offerings. The operational significance will largely depend on utilization rates, customer retention and any supporting clinical interpretation frameworks tied to the test’s performance claims.